81 FR 6877 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 26 (February 9, 2016)

Page Range		6877-6878
FR Document		2016-02536

Federal Register, Volume 81 Issue 26 (Tuesday, February 9, 2016)

[Federal Register Volume 81, Number 26 (Tuesday, February 9, 2016)]
[Notices]
[Pages 6877-6878]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-02536]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NST1 Member Conflict SEP.
    Date: March 8, 2016.
    Time: 9:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Arlington, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: William C Benzing, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-0660, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NINDS R 35 Review.
    Date: March 17-18, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Natalia Strunnikova, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-402-0288, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NINDS R35 Review.
    Date: March 17-18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Ernest W Lyons, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-4056, 
[email protected].


[[Page 6878]]


    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NINDS R35 Review.
    Date: March 17-18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Birgit Neuhuber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-3562, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; R24/P30 Review.
    Date: April 5, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Natalia Strunnikova, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-402-0288, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Udall Center Review.
    Date: April 5-6, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 
22314.
    Contact Person: Birgit Neuhuber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-3562, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: February 4, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02536 Filed 2-8-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 6877

Comment Due Date: Comments Investigator Registration Procedure in the patient to that drug. Investigators are
regarding this information collection are the Conduct of Investigational Trials for physicians who specialize in the
best assured of having their full effect if the Treatment of Cancer, 0925–0613, treatment of patients with cancer. Data
received within 30 days of the date of Expiration Date 03/31/2016, Revision, obtained from the Drug Accountability
this publication. National Cancer Institute (NCI), Record is used to track the dispensing
FOR FURTHER INFORMATION CONTACT: To National Institutes of Health (NIH). of investigational anticancer agents from
obtain a copy of the data collection Need and Use of Information receipt from the NCI to dispensing or
plans and instruments, or request more Collection: The U.S. Food and Drug administration to patients. NCI and/or
information on the proposed project, Administration (FDA) holds the its auditors use this information for
contact: Charles Hall, RPh, M.S., Chief, National Cancer Institute (NCI) compliance purposes. The frequency of
Pharmaceutical Management Branch, responsible, as a sponsor of Response is up to 16 times per year. The
Cancer Therapy Evaluation Program, investigational drug trials, for the affected public is private sector
National Cancer Institute, 9609 Medical collection of information about the including businesses, other for-profit
Center Drive, RM 5W240, MSC 9725, clinical investigators who participate in organizations, and non-profit
Bethesda, Maryland 20892. Or call non- these trials and to assure the FDA that institutions. The type of respondents are
toll-free number (240) 276–6575, or systems for accountability are being investigators, pharmacists, nurses,
email your request, include your maintained by investigators in its pharmacy technicians, and data
address to: hallch@mail.nih.gov. clinical trials program. The information managers.
Formal requests for additional plans collected is used to identify qualified OMB approval is requested for 3
and instruments must be requested in investigators and to facilitate the years. There are no costs to respondents
writing. submission and distribution of other than their time. The total
Proposed Collection: Drug important information relative to the estimated annualized burden hours are
Accountability Report Form and investigational drug and the response of 14,649 hours.

TABLE 1—ESTIMATES OF ANNUAL BURDEN
Estimated annualized burden hours

Average time
Type of Number of Number of Total hour
Form per response
respondents respondents responses burden
(in hours)

Investigators and Designee for In- Statement of Investigator ................. 22,283 1 15/60 5,571
vestigator Registration and DARF.
NCI/DCTD/CTEP Supplemental In- 22,283 1 10/60 3,714
vestigator.
Financial Disclosure Forms .............. 22,283 1 5/60 1,857
NCI/DCTD/CTEP Drug Account- 3,288 16 4/60 3,507
ability Record Form (DARF and
DARF-Oral).

Total ........................................... ........................................................... 25,571 119,457 ........................ 14,649

Dated: February 3, 2016. confidential trade secrets or commercial Agenda: To review and evaluate grant
Karla Bailey, property such as patentable material, applications.
and personal information concerning Place: Hyatt Regency Bethesda, One
Project Clearance Liaison, National Cancer
Bethesda Metro Center, 7400 Wisconsin
Institute, NIH. individuals associated with the grant
Avenue, Bethesda, MD 20814.
[FR Doc. 2016–02447 Filed 2–8–16; 8:45 am] applications, the disclosure of which Contact Person: Natalia Strunnikova,
BILLING CODE 4140–01–P would constitute a clearly unwarranted Ph.D., Scientific Review Officer, Scientific
invasion of personal privacy. Review Branch, Division of Extramural
Name of Committee: National Institute of Research, NINDS/NIH/DHHS/Neuroscience
DEPARTMENT OF HEALTH AND Neurological Disorders and Stroke Special Center, 6001 Executive Boulevard, Suite
HUMAN SERVICES Emphasis Panel; NST1 Member Conflict SEP. 3208, MSC 9529, Bethesda, MD 20892–9529,
Date: March 8, 2016. 301–402–0288, Natalia.strunnikova@nih.gov.
National Institutes of Health Time: 9:00 a.m. to 3:00 p.m. Name of Committee: National Institute of
Agenda: To review and evaluate grant Neurological Disorders and Stroke Special
National Institute of Neurological applications. Emphasis Panel; NINDS R35 Review.
Disorders and Stroke; Notice of Closed Place: Hyatt Arlington, 1325 Wilson Date: March 17–18, 2016.
Meetings Boulevard, Arlington, VA 22209. Time: 8:00 a.m. to 5:00 p.m.
Contact Person: William C Benzing, Ph.D., Agenda: To review and evaluate grant
Pursuant to section 10(d) of the Scientific Review Officer, Scientific Review applications.
Federal Advisory Committee Act, as Branch, Division of Extramural Research, Place: Hyatt Regency Bethesda, One
NINDS/NIH/DHHS/Neuroscience Center, Bethesda Metro Center, 7400 Wisconsin
mstockstill on DSK4VPTVN1PROD with NOTICES

amended (5 U.S.C. App.), notice is
6001 Executive Boulevard, Suite 3208, MSC Avenue, Bethesda, MD 20814.
hereby given of the following meetings. 9529, Bethesda, MD 20892–9529, 301–496– Contact Person: Ernest W Lyons, Ph.D.,
The meetings will be closed to the 0660, benzingw@mail.nih.gov. Scientific Review Officer, Scientific Review
public in accordance with the Branch, Division of Extramural Research,
Name of Committee: National Institute of
provisions set forth in sections Neurological Disorders and Stroke Special NINDS/NIH/DHHS/Neuroscience Center,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel; NINDS R 35 Review. 6001 Executive Boulevard, Suite 3208, MSC
as amended. The grant applications and Date: March 17–18, 2016. 9529, Bethesda, MD 20892–9529, 301–496–
the discussions could disclose Time: 8:00 a.m. to 6:00 p.m. 4056, lyonse@ninds.nih.gov.

VerDate Sep<11>2014 17:54 Feb 08, 2016 Jkt 238001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

6878 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices

Name of Committee: National Institute of DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is
Neurological Disorders and Stroke Special HUMAN SERVICES hereby given of the following meetings.
Emphasis Panel; NINDS R35 Review. The meetings will be closed to the
Date: March 17–18, 2016. National Institutes of Health public in accordance with the
Time: 8:00 a.m. to 5:00 p.m. provisions set forth in sections
Agenda: To review and evaluate grant National Institute of Allergy and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. Infectious Diseases; Notice of Closed as amended. The grant applications and
Place: Hyatt Regency Bethesda, One Meeting the discussions could disclose
Bethesda Metro Center, 7400 Wisconsin confidential trade secrets or commercial
Pursuant to section 10(d) of the
Avenue, Bethesda, MD 20814. property such as patentable material,
Federal Advisory Committee Act, as
Contact Person: Birgit Neuhuber, Ph.D., and personal information concerning
amended (5 U.S.C. App.), notice is
Scientific Review Officer, Scientific Review individuals associated with the grant
hereby given of the following meeting.
Branch, Division of Extramural Research, applications, the disclosure of which
The meeting will be closed to the
NINDS/NIH/DHHS/Neuroscience Center, would constitute a clearly unwarranted
public in accordance with the
6001 Executive Boulevard, Suite 3208, MSC invasion of personal privacy.
provisions set forth in sections
9529, Bethesda, MD 20892–9529, 301–496–
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: Oncology 2—
3562, neuhuber@ninds.nih.gov.
as amended. The contract proposals and Translational Clinical Integrated Review
Name of Committee: National Institute of the discussions could disclose Group; Chemo/Dietary Prevention Study
Neurological Disorders and Stroke Special confidential trade secrets or commercial Section.
Emphasis Panel; R24/P30 Review. property such as patentable material, Date: February 25, 2016.
Date: April 5, 2016. Time: 8:00 a.m. to 6:00 p.m.
and personal information concerning Agenda: To review and evaluate grant
Time: 8:00 a.m. to 6:00 p.m.
individuals associated with the contract applications.
Agenda: To review and evaluate grant
proposals, the disclosure of which Place: Bethesda North Marriott Hotel &
applications.
would constitute a clearly unwarranted Conference Center, 5701 Marinelli Road,
Place: Hyatt Regency Bethesda, One Bethesda, MD 20852.
invasion of personal privacy.
Bethesda Metro Center, 7400 Wisconsin Contact Person: Svetlana Kotliarova, Ph.D.,
Avenue, Bethesda, MD 20814. Name of Committee: National Institute of Scientific Review Officer, Center for
Contact Person: Natalia Strunnikova, Allergy and Infectious Diseases Special Scientific Review, National Institutes of
Emphasis Panel; ‘‘Comprehensive Resources Health, 6701 Rockledge Drive, Room 6214,
Ph.D., Scientific Review Officer, Scientific
for HIV Microbicides and Biomedical Bethesda, MD 20892, 301–594–7945,
Review Branch, Division of Extramural Prevention (N01)’’.
Research, NINDS/NIH/DHHS/Neuroscience kotliars@mail.nih.gov.
Date: February 23, 2016.
Center, 6001 Executive Boulevard, Suite Time: 8:30 a.m. to 5:00 p.m. This notice is being published less than 15
3208, MSC 9529, Bethesda, MD 20892–9529, Agenda: To review and evaluate contract days prior to the meeting due to the timing
301–402–0288, Natalia.strunnikova@nih.gov. proposals. limitations imposed by the review and
Place: National Institutes of Health, Room funding cycle.
Name of Committee: National Institute of
3F100, 5601 Fishers Lane, Rockville, MD Name of Committee: AIDS and Related
Neurological Disorders and Stroke Special Research Integrated Review Group; AIDS
20892, (Telephone Conference Call).
Emphasis Panel; Udall Center Review. Contact Person: Jay R Radke, Ph.D., AIDS Molecular and Cellular Biology Study
Date: April 5–6, 2016. Review Branch, Scientific Review Program, Section.
Time: 8:00 a.m. to 6:00 p.m. Division of Extramural Activities, Room Date: March 2, 2016.
Agenda: To review and evaluate grant #3G11B, National Institutes of Health, NIAID, Time: 8:00 a.m. to 5:00 p.m.
applications. 5601 Fishers Lane MSC–9823, Bethesda, MD Agenda: To review and evaluate grant
Place: Hotel Monaco Alexandria, 480 King 20892–9823, (240) 669–5046, jay.radke@ applications.
Street, Alexandria, VA 22314. nih.gov. Place: San Diego Marriott Mission Valley
Hotel, 8757 Rio San Diego Drive, San Diego,
Contact Person: Birgit Neuhuber, Ph.D., This notice is being published less than 15 CA 92108.
Scientific Review Officer, Scientific Review days prior to the meeting due to the timing Contact Person: Kenneth A Roebuck, Ph.D.,
Branch, Division of Extramural Research, limitations imposed by the review and Scientific Review Officer, Center for
NINDS/NIH/DHHS/Neuroscience Center, funding cycle. Scientific Review, National Institutes of
6001 Executive Boulevard, Suite 3208, MSC (Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 5214,
9529, Bethesda, MD 20892–9529, 301–496– Program Nos. 93.855, Allergy, Immunology, MSC 7852, Bethesda, MD 20892, (301) 435–
3562, neuhuber@ninds.nih.gov. and Transplantation Research; 93.856, 1166, roebuckk@csr.nih.gov.
Microbiology and Infectious Diseases Name of Committee: Center for Scientific
(Catalogue of Federal Domestic Assistance Research, National Institutes of Health, HHS)
Program Nos. 93.853, Clinical Research Review Special Emphasis Panel, PAR Panel:
Dated: February 4, 2016. Health Disparities in and Caregiving for
Related to Neurological Disorders; 93.854,
Natasha M. Copeland, Alzheimer’s Disease.
Biological Basis Research in the Date: March 4, 2016.
Neurosciences, National Institutes of Health, Program Analyst, Office of Federal Advisory
Time: 8:00 a.m. to 5:00 p.m.
HHS) Committee Policy.
Agenda: To review and evaluate grant
[FR Doc. 2016–02535 Filed 2–8–16; 8:45 am] applications.
Dated: February 4, 2016.
BILLING CODE 4140–01–P Place: Marriott Wardman Park Washington
Sylvia Neal, DC Hotel, 2660 Woodley Road NW.,
Program Analyst, Office of Federal Advisory Washington, DC 20008.
Committee Policy. DEPARTMENT OF HEALTH AND Contact Person: Gabriel B Fosu, Ph.D.,
HUMAN SERVICES Scientific Review Officer, Center for
mstockstill on DSK4VPTVN1PROD with NOTICES

[FR Doc. 2016–02536 Filed 2–8–16; 8:45 am]
Scientific Review, National Institutes of
BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 3108,
National Institutes of Health
MSC 7808, Bethesda, MD 20892, (301) 435–
Center for Scientific Review; Notice of 3562, fosug@csr.nih.gov.
Closed Meetings Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Pursuant to section 10(d) of the Reproduction, Endocrinology and Metabolic
Federal Advisory Committee Act, as Processes.

VerDate Sep<11>2014 17:54 Feb 08, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

Document Created: 2018-02-02 14:30:36
Document Modified: 2018-02-02 14:30:36

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 8, 2016.
FR Citation		81 FR 6877

81 FR 6877 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 26 (February 9, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health